Cognitive behavioural therapies for insomnia (CBT-I) are increasingly being delivered online in order to improve accessibility. However, although insomnia and anxiety frequently occur together in older adults, few… read more.
Researchers have identified the best dosage for each ADHD medication using data from thousands of people with the condition. A new study published today [14 May] in The Lancet… read more.
Current evidence does not support a causal link between the use of almost all antidepressants during pregnancy and an increased risk of neurodevelopmental disorders, including autism and attention-deficit/hyperactivity… read more.
Insomnia is a common problem, affecting as many as 20% to 60% of perimenopausal and postmenopausal US women. Because of its possible severe physical and psychological effects, ongoing… read more.
Johnson & Johnson announced that the FDA has approved a supplemental New Drug Application (sNDA) based on long-term data evaluating the safety and efficacy of Caplyta (lumateperone) for… read more.
The use of psilocybin, the hallucinogenic compound found in “magic mushrooms,” is rising in the United States alongside de‑criminalization efforts in several states and local jurisdictions, as well… read more.
People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.
Older adults who develop delirium during a hospital admission face a substantially higher risk of dementia in later years, even if they had no prior health conditions, according… read more.
A new study reveals that family caregivers of Alzheimer’s patients in Oman face significant unmet needs, ranging from limited knowledge about the disease to high psychological stress and… read more.
Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined… read more.
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is… read more.
GLP-1 medications, which are used to treat diabetes and obesity, appear to be associated with reduced hospital care and sickness absence from work for psychiatric reasons, researchers reported… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
